Production Method 1

25791-96-2

25791-96-2

823-40-5

Reaction Conditions

1.1 Reagents: Hydrogen ,  Tripotassium phosphate Catalysts: stereoisomer of [2-[Bis(1-methylethyl)phosphino-κP]-N-[2-[bis(1-methylethyl)phos… Solvents: Isopropanol ;  21 h, 30 bar, 150 °C

Reference

Catalytic Hydrogenation of Polyurethanes to Base Chemicals: From Model Systems to Commercial and End-of-Life Polyurethane Materials

Gausas, Laurynas; et al, JACS Au, 2021, 1(4), 517-524

Propoxylated glycerin Raw materials

• Propoxylated glycerin

Propoxylated glycerin Preparation Products

• 2,6-Diaminotoluene (823-40-5)
• Propoxylated glycerin (25791-96-2)

• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Research Brief on Propoxylated Glycerin (CAS 25791-96-2): Recent Advances and Applications in Chemical Biomedicine

Propoxylated glycerin (CAS 25791-96-2), a polyether polyol derived from glycerin, has garnered significant attention in the chemical biomedicine field due to its versatile applications in drug delivery, biomaterials, and pharmaceutical formulations. Recent studies have explored its unique physicochemical properties, including tunable hydrophilicity, biocompatibility, and low toxicity, which make it an attractive candidate for various biomedical applications. This research brief synthesizes the latest findings on propoxylated glycerin, focusing on its synthesis, characterization, and emerging uses in the healthcare sector.

A 2023 study published in the Journal of Controlled Release investigated the use of propoxylated glycerin as a solubilizing agent for poorly water-soluble drugs. The researchers demonstrated that propoxylated glycerin significantly enhanced the solubility and bioavailability of several hydrophobic active pharmaceutical ingredients (APIs), including anticancer and antifungal agents. The study attributed this effect to the amphiphilic nature of propoxylated glycerin, which enables the formation of micellar structures in aqueous solutions. These findings suggest promising applications in oral and topical drug formulations where solubility enhancement is critical.

In the realm of biomaterials, a team from MIT reported novel findings in Biomaterials Science (2024) regarding the use of propoxylated glycerin as a plasticizer for biodegradable polymers. The study showed that incorporating propoxylated glycerin into polylactic acid (PLA) matrices improved the mechanical flexibility and degradation kinetics of the resulting composites while maintaining biocompatibility. This advancement opens new possibilities for developing next-generation medical implants and tissue engineering scaffolds with tailored properties.

Recent toxicological assessments (2024) published in Regulatory Toxicology and Pharmacology have further solidified the safety profile of propoxylated glycerin for pharmaceutical applications. Comprehensive in vitro and in vivo studies confirmed its low cytotoxicity and minimal irritation potential, even at high concentrations. These results support the continued use of propoxylated glycerin in topical formulations and as an excipient in various drug delivery systems.

Emerging research has also explored the potential of propoxylated glycerin in vaccine adjuvants. A 2024 study in Vaccine demonstrated that propoxylated glycerin-based emulsions could effectively stimulate both humoral and cellular immune responses when used as adjuvant systems. This application capitalizes on the compound's ability to stabilize antigen presentations while modulating immune cell interactions, offering a promising alternative to traditional adjuvant formulations.

From an industrial perspective, advancements in the green synthesis of propoxylated glycerin have been reported in Green Chemistry (2023). Researchers developed a catalytic process using environmentally benign catalysts that significantly reduced energy consumption and byproduct formation during production. This sustainable approach aligns with the growing demand for eco-friendly pharmaceutical ingredients and may influence future manufacturing standards for polyether polyols.

Looking forward, the unique properties of propoxylated glycerin (CAS 25791-96-2) position it as a multifunctional platform for diverse biomedical applications. Current research directions include its exploration in targeted drug delivery systems, 3D bioprinting inks, and as a component in smart responsive materials. The compound's versatility, combined with its established safety profile, suggests it will remain an important focus of research in chemical biomedicine for years to come.

• 667933-74-6(4-[3-(Methoxymethoxy)propoxy]butane-1,2,3-triol)
• 5399-31-5(4,4'-Bi-1,3-dioxolane,(R*,S*)- (9CI))
• 91299-48-8(OXIRANE, 2-[[(2-METHOXYETHOXY)METHOXY]METHYL]-3-METHYL-, TRANS-)
• 286-48-6(3,5,8-Trioxabicyclo[5.1.0]octane)
• 765-98-0(2,7,8-TRIOXABICYCLO[3.2.1]OCTANE)
• 123125-18-8(((4S,5S)-2-ethoxy-1,3-dioxolane-4,5-diyl)diMethanol)
• 166734-76-5(1,4-Butanediol, 2,3-bis(methoxymethoxy)-, (2R,3R)-)
• 169310-84-3(1,2-Butanediol, 4-[(2-methoxyethoxy)methoxy]-, (R)-)
• 57626-97-8(1,3-DIOXEPANE, 5-METHOXY-)
• 99891-36-8(1,4-Butanediol, 2,3-bis(methoxymethoxy)-, (2S,3S)-)